Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP819215.RAKKG8HrNFQaHXG4wPQMN3Oe9IYC-EtlF-vCOF0_opQxk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP819215.RAKKG8HrNFQaHXG4wPQMN3Oe9IYC-EtlF-vCOF0_opQxk130_assertion type Assertion NP819215.RAKKG8HrNFQaHXG4wPQMN3Oe9IYC-EtlF-vCOF0_opQxk130_head.
- NP819215.RAKKG8HrNFQaHXG4wPQMN3Oe9IYC-EtlF-vCOF0_opQxk130_assertion description "[The most suitable immunohistochemical criterion to identify basal-like breast carcinomas (BLBC), a molecular subgroup of breast cancer associated with poor prognosis, is the triple negative phenotype along with CK5 and/or EGFR immunoreactivity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP819215.RAKKG8HrNFQaHXG4wPQMN3Oe9IYC-EtlF-vCOF0_opQxk130_provenance.
- NP819215.RAKKG8HrNFQaHXG4wPQMN3Oe9IYC-EtlF-vCOF0_opQxk130_assertion evidence source_evidence_literature NP819215.RAKKG8HrNFQaHXG4wPQMN3Oe9IYC-EtlF-vCOF0_opQxk130_provenance.
- NP819215.RAKKG8HrNFQaHXG4wPQMN3Oe9IYC-EtlF-vCOF0_opQxk130_assertion SIO_000772 20552547 NP819215.RAKKG8HrNFQaHXG4wPQMN3Oe9IYC-EtlF-vCOF0_opQxk130_provenance.
- NP819215.RAKKG8HrNFQaHXG4wPQMN3Oe9IYC-EtlF-vCOF0_opQxk130_assertion wasDerivedFrom befree-2016 NP819215.RAKKG8HrNFQaHXG4wPQMN3Oe9IYC-EtlF-vCOF0_opQxk130_provenance.
- NP819215.RAKKG8HrNFQaHXG4wPQMN3Oe9IYC-EtlF-vCOF0_opQxk130_assertion wasGeneratedBy ECO_0000203 NP819215.RAKKG8HrNFQaHXG4wPQMN3Oe9IYC-EtlF-vCOF0_opQxk130_provenance.